1. Home
  2. RGNX vs VALU Comparison

RGNX vs VALU Comparison

Compare RGNX & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • VALU
  • Stock Information
  • Founded
  • RGNX 2008
  • VALU 1931
  • Country
  • RGNX United States
  • VALU United States
  • Employees
  • RGNX N/A
  • VALU N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • VALU Investment Managers
  • Sector
  • RGNX Health Care
  • VALU Finance
  • Exchange
  • RGNX Nasdaq
  • VALU Nasdaq
  • Market Cap
  • RGNX 387.0M
  • VALU 379.6M
  • IPO Year
  • RGNX 2015
  • VALU N/A
  • Fundamental
  • Price
  • RGNX $6.76
  • VALU $40.07
  • Analyst Decision
  • RGNX Strong Buy
  • VALU
  • Analyst Count
  • RGNX 9
  • VALU 0
  • Target Price
  • RGNX $32.89
  • VALU N/A
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • VALU 9.2K
  • Earning Date
  • RGNX 05-07-2025
  • VALU 03-14-2025
  • Dividend Yield
  • RGNX N/A
  • VALU 3.00%
  • EPS Growth
  • RGNX N/A
  • VALU 17.96
  • EPS
  • RGNX N/A
  • VALU 2.28
  • Revenue
  • RGNX $83,328,000.00
  • VALU $35,695,000.00
  • Revenue This Year
  • RGNX $285.14
  • VALU N/A
  • Revenue Next Year
  • RGNX N/A
  • VALU N/A
  • P/E Ratio
  • RGNX N/A
  • VALU $16.93
  • Revenue Growth
  • RGNX N/A
  • VALU N/A
  • 52 Week Low
  • RGNX $5.62
  • VALU $32.94
  • 52 Week High
  • RGNX $21.19
  • VALU $57.68
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • VALU 52.76
  • Support Level
  • RGNX $7.96
  • VALU $37.60
  • Resistance Level
  • RGNX $8.35
  • VALU $40.79
  • Average True Range (ATR)
  • RGNX 0.65
  • VALU 1.51
  • MACD
  • RGNX -0.04
  • VALU 0.10
  • Stochastic Oscillator
  • RGNX 13.21
  • VALU 67.67

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under well-known brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and The Most Trusted Name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: